Key result
Non-compliance with aspirin therapy was the strongest risk factor for in-hospital mortality among several quality-of-care indicators assessed in Chinese patients with acute myocardial infarction.
Why the study?
Does compliance with quality-of-care indicators reduce in-hospital mortality in patients with acute myocardial infarction?
Observational (n=2,128)
Yes
Does compliance with quality-of-care indicators reduce in-hospital mortality in patients with acute myocardial infarction?
Adherence to guideline-directed quality-of-care indicators for acute myocardial infarction is significantly associated with reduced in-hospital mortality, highlighting the clinical importance of closing practice gaps.
Answers are grounded in this paper and cite their sources.
Aspirin non-compliance warrants attention in Chinese AMI care; extends quality-indicator associations but leaves causal mortality reduction open.
There is a wide practice gap between optimal care and actual care for patients with acute myocardial infarction (AMI) in China. Indicators of quality of care for AMI patients have already been developed by a modified Delphi process. Our aim was to assess the association between those indicators and in-hospital mortality in AMI patients. We hypothesized that an association exists between quality-of-care indicators and in-hospital mortality in AMI patients. Based on the data of 2128 AMI patients at 20 tertiary hospitals in Heilongjiang Province from January 1, 2009 to October 31, 2010, we estimated the compliance rates of indicators. Association between indicators and in-hospital mortality was assessed using hierarchical generalized linear models. Among 2128 patients, 163 (7.66%) died during their hospital stay. The compliance rates were 71.6%, 41.3%, 82.5%, 63.5%, 80.4%, 5.1%, 28.9%, and 41.2% for the use of aspirin, β-blocker, clopidogrel, angiotensin-converting enzyme inhibitor, statin, thrombolytic, percutaneous coronary intervention, and coronary angiography, respectively. Aspirin, clopidogrel, angiotensin-converting enzyme inhibitor, statin, and percutaneous coronary intervention were significantly associated with in-hospital mortality after adjustment for potential confounding factors. We found some disparities between guidelines and clinical practice for AMI patients in China and a significant association between indicators and in-hospital mortality. Our findings are potentially helpful for assessing and improving the quality of care for AMI patients in China.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2015) conducted an observational in Acute Myocardial Infarction (n=2,128). Non-compliance with aspirin therapy vs. Compliance with aspirin therapy was evaluated on In-hospital mortality (OR 3.07, 95% CI 1.55-6.08, p=0.0028). Non-compliance with aspirin therapy was the strongest risk factor for in-hospital mortality among several quality-of-care indicators assessed in Chinese patients with acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: